Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Sep;14(3):247-50.
doi: 10.4048/jbc.2011.14.3.247. Epub 2011 Sep 29.

Invasive lobular breast cancer presenting an unusual metastatic pattern in the form of peritoneal and rectal metastases: a case report

Djordjije Saranovic  1 , Jelena Djokic Kovac, Srbislav Knezevic, Snezana Susnjar, Aleksandra Djuric Stefanovic, Dragana Sobic Saranovic, Vera Artiko, Vladimir Obradovic, Dragan Masulovic, Marjan Micev, Predrag Pesko
Affiliations
Case Reports

Invasive lobular breast cancer presenting an unusual metastatic pattern in the form of peritoneal and rectal metastases: a case report

Djordjije Saranovic et al. J Breast Cancer. 2011 Sep.

Abstract

Gastrointestinal metastases from invasive lobular breast cancer are uncommon with the stomach and small intestines being the most common metastatic sites. Peritoneal and rectal metastases are very rare and only rarely occur as the first manifestation of disease. We herein report the case of a 47-year-old woman who presented with abdominal carcinomatosis as a first sign of invasive lobular breast carcinoma (ILC). Identifying the most important immunohistochemical markers for ILC: gross cystic disease fluid protein 15, estrogen and progesterone receptors enabled a correct diagnosis. After a six year disease-free period, relapse occurred with severe obstruction due to rectal metastasis from lobular breast carcinoma. Since there was no widespread metastatic disease, surgery with concomitant hormonal therapy was performed.

Keywords: Breast; Lobular carcinoma; Neoplasm metastasis; Peritoneum; Rectum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histological features of peritoneal metastasis (A) and breast biopsy: invasive lobular breast carcinoma (B) (H&E stain, ×100).
Figure 2
Figure 2
Turbo-spin-echo fat suppression T1 weighted (A) and turbo-spin-echo T2 weighted axial (B) and sagittal (C) MR image show a stage T3 rectal tumor. The tumor has intermediate signal intensity between the high signal intensity of the fat tissue and the low signal intensity of the muscular layer. Tumor signal intensity extends through the muscle layer into the perirectal fat, with obliteration of the interface between muscle and perirectal fat.
Figure 3
Figure 3
18F-FDG-PET/CT findings. (A) Axial computerized tomography (CT) image shows circumferential rectal wall thickening. (B) Axial CT attenuation-colorectal positron-emission tomography (PET) image and axial fused PET/CT image (C) revealed area of increased fluorine18-fluoro-deoxy-glucose (18F-FDG) uptake in rectal wall (standardized uptake value, SUVmax=9.8). (D) Increased uptake of 18F-FDG is also seen on maximum intensity projection reconstruction of CT attenuation-corrected PET image.
Figure 4
Figure 4
Histological and immunohistochemical features of rectal biopsy. (A) Diffuse carcinomatous infiltration of the rectal wall, mostly in the basal layer of mucosa and superficial submucosa. (B) Immunohistochemistry depicted strong immunoreactivity to gross cystic disease fluid protein 15 antigen (Immunohistochemical stain, ×100).
Figure 5
Figure 5
Clinical course of metastatic invasive lobular breast carcinoma. Signs and symptoms (☆) of the disease at the time of presentation and six years later. At first the patient underwent hysterectomy and salpingo-oophorectomy because of suspected ovarian cancer with peritoneal dissemination. After the diagnosis of metastatic invasive lobular breast cancer was made the patient received chemotherapy (FAC protocol) and tamoxifen remaining disease free for six years. The recurrence of disease was treated surgically with concomitant hormone therapy.
See this image and copyright information in PMC

References

    1. Winston CB, Hadar O, Teitcher JB, Caravelli JF, Sklarin NT, Panicek DM, et al. Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. AJR Am J Roentgenol. 2000;175:795–800. - PubMed
    1. Sickles EA. The subtle and atypical mammographic features of invasive lobular carcinoma. Radiology. 1991;178:25–26. - PubMed
    1. Sato T, Ohwada A, Miyaji A, Miyazaki R, Suzuki M, Matsumoto T. Immunohistochemistry for the differentiation of peritoneal disseminated carcinoma of unknown origin. Intern Med. 2004;43:415–419. - PubMed
    1. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996;13:1919–1925. - PubMed
    1. Venanzi FM, Soverchia L, Felicetti P, Mennecozzi M, Concetti A. HER2/neu oncogene sequence revisited. J Natl Cancer Inst. 2002;94:1808–1809. - PubMed

Publication types